Riata ICD Lead Summit Agenda

To access the content archive, you must first register or login.

If you are already logged in, you may click here to view the archive.

Introduction & Goals 

David L. Hayes, MD

Riata Leads: What do we know, what are the questions?

Robert G. Hauser, MD

The Northern Ireland Experience

Ernest W. Lau, MD

The Independent Multicenter Study: Preliminary Results

Raed. H. Abdelhadi, MD

Lead Survival: VA National Cardiac Device Surveillance Experience

Edmund C. Keung, MD

St. Jude's Perspective

Mark D. Carlson, MD

Panel Session: Clinical Experiences with Riata Leads

David L. Hayes, MD, Chair; Drs. Saba, Epstein, DiMarco, Trohman, Friedman, Swerdlow, Kramer, Lau and Love, and Melanie Gura, RN

Fluroscopic Examination of Riata Leads

Christopher R. Ellis, MD

Riata Lead Extraction: Methods and Results

Laurence M. Epstein, MD

Riata Clinical Follow-up: Diagnostic Data and Measurements

Ken A. Ellenbogen, MD

Remote Follow-Up: What are the options?

Charles D. Swerdlow, MD

Panel Session: Patient Management

David L. Hayes, MD, Chair; Drs. Carrillo, Vatterott, Bazaz, Swerdlow, Epstein, Ellenbogen, DiMarco and Love, and Linda Kallinen Retel

Summary and Consensus

Robert G. Hauser, MD